Jan 27, 2023
FDA
The article provides an overview of the factors resulting in delaying or refusing an inspection. Table of Contents The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere of healthcare products, has published a draft guidance...
Read More
Jan 27, 2023
FDA
The new article highlights the aspects related to limitations the authority may impose with respect to the application of the program for certain medical devices or scenarios. Table of Contents The Food and Drug Administration (FDA or the Agency), the US authority in...
Read More
Jan 27, 2023
FDA
The new article addresses the aspects related to the scope of events eligible for the program, as well as to its general conditions. Table of Contents The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere of healthcare...
Read More
Jan 26, 2023
FDA
The new article highlights the key points related to specific products eligible for the program, their periodic evaluation, and eligibility requests. Table of Contents The Food and Drug Administration (FDA or the Agency), has published a draft guidance document...
Read More
Jan 16, 2023
FDA
The new article addresses the aspects related to the principles to be followed with respect to voluntary reporting, and also describes the approach the authority applies when determining the eligibility criteria to be considered. Table of Contents The Food and Drug...
Read More